Ozempic manufacturer Novo Nordisk said patient safety is a priority and “the benefit-risk profile of semaglutide remains ...

Food companies fatten us up only for Big Pharma to let us inject ourselves slim again. Crazy? Perhaps it’s the beginning of ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been ...

Hims & Hers Health (NYSE:HIMS) is down 7% in early morning trading after the U.S. FDA determined that there is no shortage of ...

Gavin and Stacey star James Corden previously opened up about his weight loss and why he stopped using Ozempic ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Known as glucagon-like peptide-1 (GLP-1) receptor agonists, blockbuster drugs such as Ozempic, Wegovy, Mounjaro, Zepbound, ...

Streaming outperforms linear TV: Streaming ads for diabetes drugs were 6% more effective than linear TV in driving consumer ...

The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a ...

DeMarcus Cousins and Michelle Beadle call out Zion Williamson, raising concerns about the Pelicans star's weight and fitness ...

That's why Novo Nordisk's shares are worth sticking with for good, and at about $108 apiece, investors can afford two of them ...

In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.